Innovent Biologics

(OTC) IVBXF

Current Price$9.79

Market Cap$17.02B

Since IPO (2019)+210%

5 Year-12%

1 Year-3%

1 Month-9%

Innovent Biologics Financials at a Glance

Market Cap

$17.02B

Revenue (TTM)

CN¥22.35B

Net Income (TTM)

CN¥719.28M

EPS (TTM)

$0.07

P/E Ratio

143.34

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$9.79

Volume

1,642

Open

$9.50

Price

$9.79

Volume

1,642

Open

$9.50

Previous Close

$9.79

Daily Range

$9.33 - $9.79

52-Week Range

$9.10 - $15.12

Estimated Earnings Date

Aug 26, 2026

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$9.79

Volume

1,642

Open

$9.50

Previous Close

$9.79

Daily Range

$9.33 - $9.79

52-Week Range

$9.10 - $15.12

Estimated Earnings Date

Aug 26, 2026

IVBXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Innovent Biologics

Industry

Biotechnology

Sector

Health Care

Employees

7,502

CEO

De Chao Yu, PhD

Website

www.innoventbio.com

Headquarters

Suzhou, 215123, CN

IVBXF Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

0.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.02B

Shares Outstanding

1.74B

Volume

1.64K

Avg. Volume

5.44K

Financials (TTM)

Gross Profit

CN¥10.99B

Operating Income

CN¥1.97B

EBITDA

CN¥1.97B

Operating Cash Flow

CN¥10.00B

Capital Expenditure

-CN¥683.27M

Free Cash Flow

CN¥9.32B

Cash & ST Invst.

CN¥18.24B

Total Debt

CN¥2.82B

Innovent Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CN¥6.97B

+98.9%

Gross Profit

CN¥6.06B

+144.5%

Gross Margin

86.98%

N/A

Market Cap

$17.02B

N/A

Market Cap/Employee

$3.01M

N/A

Employees

5,659

N/A

Net Income

-CN¥20.41M

+97.7%

EBITDA

CN¥715.65M

+196.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CN¥18.24B

+66.3%

Total Debt

CN¥2.82B

-22.2%

Accounts Receivable

CN¥1.75B

+74.2%

Inventory

CN¥1.30B

+34.5%

Long Term Debt

CN¥2.02B

-16.0%

Short Term Debt

CN¥811.63M

-33.5%

Return on Assets

2.18%

N/A

Return on Invested Capital

2.53%

N/A

Free Cash Flow

CN¥9.43B

+3685.2%

Operating Cash Flow

CN¥9.66B

+1153.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WXXWYWuXi Biologics (Cayman) Inc.

WXXWYWuXi Biologics (Cayman) Inc.$7.89+4.46%

WXIBFWuXi Biologics (Cayman) Inc.

WXIBFWuXi Biologics (Cayman) Inc.$4.40+0.00%

GNMSFGenmab A/S

GNMSFGenmab A/S$249.00+0.00%

GIKLYGrifols, S.A.

GIKLYGrifols, S.A.$5.69+0.00%

SUVPFSartorius AG

SUVPFSartorius AG$288.22+0.00%

SBMFFSino Biopharmaceutical Limited

SBMFFSino Biopharmaceutical Limited$0.63+0.00%

SBHMYSino Biopharmaceutical Limited

SBHMYSino Biopharmaceutical Limited$11.27+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

Questions About IVBXF

What is the current price of Innovent Biologics?

Innovent Biologics is trading at $9.79 per share.

What is the 52-week range for Innovent Biologics?

Over the past 52 weeks, Innovent Biologics has traded between $9.10 and $15.12.

How much debt does Innovent Biologics have?

As of the most recent reporting period, Innovent Biologics reported total debt of CN¥402.94M.

How much cash does Innovent Biologics have on hand?

Innovent Biologics reported CN¥1.48B in cash and cash equivalents in its most recent financial results.

What is Innovent Biologics’s dividend yield?

Innovent Biologics does not currently have a dividend yield.

Innovent Biologics

Innovent Biologics Financials at a Glance

IVBXF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Innovent Biologics

IVBXF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Innovent Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IVBXF

What is the current price of Innovent Biologics?

What is the 52-week range for Innovent Biologics?

How much debt does Innovent Biologics have?

How much cash does Innovent Biologics have on hand?

What is Innovent Biologics’s dividend yield?

Premium Investing Services